Abstract
BackgroundPandemics pose significant challenges for healthcare systems, including an increase in difficult discussions about future illness progression and end of life.ObjectivesTo synthesise existing evidence about communication practices used to discuss difficult matters, including prognosis and end of life, and to use this evidence to make recommendations for clinical practice. The aim of this study was to use rapid review methods to update findings from a previous systematic review published in 2014.Data sourcesMEDLINE, EMBASE, CINAHL, PsycINFO, Sociological Abstracts, Web of Science, Scopus, ASSIA and Amed.Study eligibility criteriaStudies using conversation analysis or discourse analysis to examine recordings of actual conversations about difficult matters relating to future illness progression and end of life.Study appraisal and synthesis methodsData appraisal and extraction procedures used in the 2014 review were modified for this rapid review.ResultsFollowing screening, 18 sources were deemed to meet eligibility criteria, which were added to the 19 sources included in the 2014 systematic review. Synthesis of study findings identified 11 communication practices: providing opportunities for patient or family members to propose matters to discuss (7 out of 37 included sources); seeking a patient or family member’s perspective (6/37); discussing the future indirectly (11/37); discussing the future explicitly (7/37) linking to something previously said or done (11/37); using hypothetical scenarios (13/37); framing a difficult matter as universal (5/37); acknowledging uncertainty (3/37); exploring options (2/37); displaying sensitivity (7/37); emphasising the positive (7/37).LimitationsDividing work amongst the study authors to enable rapid review may have created inconsistencies.Conclusions and implications of key findingsThis synthesis of high-quality evidence from actual clinical practice supports a series of recommendations for communicating about difficult matters during and beyond the COVID-19 pandemic.
Publisher
Cold Spring Harbor Laboratory
Reference71 articles.
1. Liu W , Tao Z-W , Lei W , et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Medical Journal in press.
2. Sun P , Qie S , Liu Z , Ren J , Li K , Xi J . Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. Journal of medical virology 2020.
3. Which lessons shall we learn from the 2019 novel coronavirus outbreak;Ann Transl Med,2020
4. Mo P , Xing Y , Xiao Y , et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases 2020.
5. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献